NCT00298688View on ClinicalTrials.gov

A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

March 31, 2007

Conditions

Small Cell Lung Cancer

Interventions

DRUG

Gefitinib

Trial Locations (3)

Unknown

Research Site, Copenhagen

Research Site, Herlev

Research Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY